mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.5 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.5 |